GlassScriptPhysician profile
Daniel James London
NPI 1932581931
$703.55
in general payments reported to CMS, 2019-2025
15 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2023: $16.13 · 2024: $157 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $141.00 | 2019 | |
| Horizon Therapeutics Plc | $104.05 | 2019 | |
| Celularity INC. | $77.00 | 2019 | |
| Smith+Nephew, INC. | $59.82 | 2024-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Djo, LLC | $54.97 | 2024-2025 | Cmf |
| Stryker Corporation | $54.79 | 2024-2025 | Augment Injectable, Prostep |
| Depuy Synthes Sales INC. | $35.59 | 2019-2023 | Hammerlock |
| Paratek Pharmaceuticals, INC. | $35.58 | 2024-2025 | Nuzyra |
| Kerecis Limited | $27.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $20.14 | 2025 | |
| Orthofix Medical, INC. | $19.67 | 2025 | Physio-Stim |
| Bioventus LLC | $19.26 | 2025 | Exogen Ultrasound Bone Healing System |
| Aroa Biosurgery Incorporated | $19.26 | 2025 | |
| Organogenesis INC. | $18.11 | 2025 | Nushield |
| Mimedx Group, INC. | $17.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel London listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.